XML 52 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenue:    
Product revenue $ 219,392 $ 205,768
Service revenue 140,811 126,338
Total revenue 360,203 332,106
Cost of Revenue:    
Cost of product revenue 78,042 74,150
Cost of service revenue 80,064 73,982
Total cost of revenue 158,106 148,132
Gross profit 202,097 183,974
Expenses:    
Sales and marketing 67,848 59,397
General and administrative 41,089 41,631
Research and development 23,114 21,758
Income from operations 70,046 61,188
Interest expense (2,774) (835)
Interest income 471 444
Income before provision for income taxes 67,743 60,797
Provision for income taxes 21,150 15,930
Net income 46,593 44,867
Less: Net income attributable to noncontrolling interest 8 7
Net income attributable to IDEXX Laboratories, Inc. stockholders $ 46,585 $ 44,860
Earnings per Share:    
Basic $ 0.90 $ 0.82
Diluted $ 0.89 $ 0.81
Weighted Average Shares Outstanding:    
Basic 51,617 54,588
Diluted 52,338 55,490